Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
49.91
-0.55 (-1.09%)
At close: Mar 13, 2026, 4:00 PM EDT
49.90
-0.01 (-0.02%)
After-hours: Mar 13, 2026, 4:25 PM EDT

Supernus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-38.5573.871.3260.7153.42
Depreciation & Amortization
91.5680.4184.8685.5432.6
Stock-Based Compensation
33.0527.7626.7617.5717.91
Other Adjustments
36.43-8.037.29-24.8519.63
Change in Receivables
-22.32.0818.77-16.373.87
Changes in Inventories
-7.515.816.11-17.86-14.58
Changes in Accrued Expenses
-7.6114.432.6118.944.5
Changes in Other Operating Activities
-37.75-34.37-36.62-6.869.78
Operating Cash Flow
47.33171.95111.09116.83127.13
Operating Cash Flow Growth
-72.47%54.79%-4.91%-8.10%-8.14%
Capital Expenditures
-1.34-0.73-0.55-0.41-2.05
Purchases of Investments
-475.94-688.01-101.62-406.99-311.57
Proceeds from Sale of Investments
774.48498.87370.9190.74530.51
Payments for Business Acquisitions
-293.09----311.69
Other Investing Activities
----12.89
Investing Cash Flow
4.11-189.87268.73-216.66-81.91
Short-Term Debt Issued
--93--
Short-Term Debt Repaid
---93--
Long-Term Debt Issued
----0.8
Long-Term Debt Repaid
---402.5--138.32
Net Long-Term Debt Issued (Repaid)
---402.5--137.52
Issuance of Common Stock
37.6214.916.6112.427.1
Net Common Stock Issued (Repurchased)
37.6214.916.6112.427.1
Other Financing Activities
-28.49-2.72-1.99-22.9-
Financing Cash Flow
9.1312.19-397.88-10.48-130.42
Net Cash Flow
60.57-5.72-18.07-110.31-85.21
Free Cash Flow
45.99171.23110.53116.41125.08
Free Cash Flow Growth
-73.14%54.91%-5.05%-6.93%-7.15%
FCF Margin
6.40%25.87%18.19%17.45%21.57%
Free Cash Flow Per Share
0.813.061.991.892.30
Levered Free Cash Flow
-1.18149.42-344.78140.07-53.84
Unlevered Free Cash Flow
-11.6137.1953.9125.4593.06
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q